Galapagos NV
GLPG
#4738
Rank
โ‚ฌ1.71 B
Marketcap
25,53ย โ‚ฌ
Share price
-1.14%
Change (1 day)
16.33%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -0,28ย โ‚ฌ

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -0,29ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 1,01ย โ‚ฌ a decrease over its 2023 EPS that were of 3,08ย โ‚ฌ.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,28ย โ‚ฌ-127.68%
20241,01ย โ‚ฌ-67.16%
20233,08ย โ‚ฌ-199.64%
2022-3,09ย โ‚ฌ99.03%
2021-1,55ย โ‚ฌ-68.98%
2020-5,01ย โ‚ฌ-298.06%
20192,53ย โ‚ฌ-554.64%
2018-0,56ย โ‚ฌ-77.18%
2017-2,44ย โ‚ฌ-326.21%
20161,08ย โ‚ฌ-134.19%
2015-3,15ย โ‚ฌ-371.34%
20141,16ย โ‚ฌ-445.98%
2013-0,34ย โ‚ฌ32.88%
2012-0,25ย โ‚ฌ-82.07%
2011-1,41ย โ‚ฌ-817.9%
20100,20ย โ‚ฌ12.73%
20090,17ย โ‚ฌ-120.79%
2008-0,84ย โ‚ฌ-37.67%
2007-1,34ย โ‚ฌ39.64%
2006-0,96ย โ‚ฌ28.17%
2005-0,75ย โ‚ฌ6.25%
2004-0,71ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,67ย โ‚ฌ-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3,25ย โ‚ฌ-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
2,08ย โ‚ฌ-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,79ย โ‚ฌ-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,34ย โ‚ฌ-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5,15ย โ‚ฌ-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
3,27ย โ‚ฌ-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-0,53ย โ‚ฌ 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,08ย โ‚ฌ-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel